The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Chronic Mesenteric Ischemia

Postprandial abdominal pain, sitophobia, and weight loss caused by atherosclerotic stenosis of the mesenteric arteries; diagnosed with CT angiography and treated with endovascular revascularization or open bypass.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dahiliye (İç Hastalıkları) department. Book Appointment →

What is Chronic Mesenteric Ischemia?

Chronic mesenteric ischemia (CMI) is a syndrome of inadequate intestinal blood flow during the increased demand of digestion. It typically arises from progressive atherosclerotic stenosis or occlusion of the mesenteric arteries. Hemodynamically significant disease usually requires involvement of at least two of the three main mesenteric vessels (celiac, superior mesenteric, inferior mesenteric) due to extensive collateral circulation; isolated SMA disease can be symptomatic if collaterals are inadequate.

Other etiologies include median arcuate ligament syndrome (extrinsic celiac compression), fibromuscular dysplasia, vasculitis (Takayasu, polyarteritis nodosa), radiation arteriopathy, and chronic non-occlusive mesenteric ischemia. CMI is most common in women (3:1) over 60 with widespread atherosclerosis, smoking history, and known coronary or peripheral arterial disease.

Diagnosis is built on the classic triad and confirmed with CT angiography or mesenteric duplex ultrasound; gastric tonometry and exercise testing are research tools. Treatment goals are symptom relief, weight restoration, and prevention of acute mesenteric infarction. Endovascular stenting has replaced open bypass as first-line in most centers; both interventions require lifelong antiplatelet therapy and aggressive cardiovascular risk modification.

Symptoms

Postprandial cramping or dull mid-abdominal pain 15-60 min after eating
Pain duration 1-3 hours, often forcing patients to lie down or vomit
Sitophobia (fear of food) leading to small meals and progressive weight loss
Significant unintentional weight loss over months
Diarrhea, nausea, malabsorption, steatorrhea
Audible abdominal bruit in 50-70% of cases
Background of widespread atherosclerosis (coronary, carotid, peripheral artery disease)

Risk Factors

Atherosclerosis: smoking, hypertension, diabetes, dyslipidemia
Female sex, age over 60
Established cardiovascular disease (CAD, PAD, CVD)
Chronic kidney disease, heart failure with low cardiac output
Vasculitis: Takayasu arteritis, polyarteritis nodosa
Median arcuate ligament syndrome (especially younger women)
Prior abdominal radiation therapy

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Recurrent postprandial pain with significant weight loss
  • Fear of eating combined with progressive weight loss
  • Known atherosclerosis with new chronic abdominal pain
  • Acute worsening to constant severe pain (concern for acute mesenteric ischemia)
  • After exclusion of common causes (peptic disease, gallstones, malignancy)
  • Prior to elective surgery to assess perfusion when CMI suspected
  • Follow-up after stenting or bypass to monitor patency

Treatment Methods

01
Risk factor optimization: smoking cessation, statin therapy, antiplatelet (aspirin), blood pressure and diabetes control
02
Nutritional support with small frequent meals, oral supplements, and dietitian-led repletion
03
Endovascular revascularization with mesenteric artery angioplasty and stenting (covered or balloon-expandable) as first-line in most patients
04
Open bypass (antegrade or retrograde) for complex anatomy, long occlusions, failed endovascular therapy, or younger fit patients seeking durability
05
Median arcuate ligament release (laparoscopic or robotic) for celiac compression syndrome
06
Postprocedural surveillance with mesenteric duplex at 3, 6, 12 months and yearly to detect restenosis
07
Lifelong dual antiplatelet for 1-3 months after stenting then long-term aspirin; multidisciplinary follow-up with vascular surgery, gastroenterology, and nutrition

Which Department to Visit?

You can visit our Dahiliye (İç Hastalıkları) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dahiliye (İç Hastalıkları) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.